🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-03-08
Trial ID
NCT01022138
Treatments Being Tested
This phase I trial studies the side effects and best dose of ipilimumab and...
Status
Completed
Location
Yale University
Start Date
2012-12-14
Trial ID
NCT01757639
Treatments Being Tested
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
RATIONALE: Studying samples of blood from patients treated with sargramosti...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-28
Trial ID
NCT01388569
Treatments Being Tested
The main purpose of this trial is to investigate the effects of a new class...
Status
Completed
Location
Northwestern University
Start Date
2016-11-01
Trial ID
NCT02794883
Treatments Being Tested
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be a...
Status
Terminated
Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Start Date
2007-02
Trial ID
NCT00667901